Testing effectiveness (Phase 2)Study completedNCT01280695
What this trial is testing
A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
Who this might be right for
Diabetes Mellitus, Type 2
Metabolic Solutions Development Company 129